Key result
ERAS program for pancreatoduodenectomy achieves high compliance with a ~27% complication rate and no mortality.
Why the study?
Practical application of accelerated recovery programs after surgery without compromising safety remains debatable, prompting an assessment of ERAS feasibility and impact in patients undergoing pancreatoduodenectomy.
Does the ERAS program improve postoperative outcomes in patients undergoing pancreatoduodenectomy?
Observational (n=60)
No
Does the ERAS program improve postoperative outcomes in patients undergoing pancreatoduodenectomy?
The ERAS program can be successfully implemented in patients undergoing pancreatoduodenectomy, potentially decreasing hospital stay without increasing complications.
ERAS appears feasible in pancreatoduodenectomy cohorts; leaves open whether it improves outcomes versus standard care in randomized trials.
Annotation. A number of issues concerning the practical application of the program of accelerated recovery of patients after surgery without compromising their safety remain debatable. The purpose of this study was to assess the feasibility of ERAS program for patients who undergo pancreatoduodenectomy (PD) and its impact on postoperative results. The study included 60 patients from 28 to 75 years old with benign and malignant pathologies of the pancreas and ampullary region, in which PD was performed between January 2015 and December 2018. The preoperative components of ERAS program were fulfilled in all patients. Mathematical data processing was performed using the software Statistica 64 ver. 10.0.1011.0 (StatSoft Inc.). All intraoperative components were implemented (100%) (except for epidural anesthesia – 85%). Postoperative components of ERAS program were implemented in the range from 56.7% to 100%. There was no postoperative mortality. Complications were observed in 16 (26.7%) patients in whom total number of complications was 22. The average duration of hospital stay after surgery was 13.1±4.1 days. The most of components of ERAS program for PD patients can be successfully implemented, decreasing the lengths of hospital stay without increase in number of postoperative complications.
No takes yet. Share an insight, caveat, or question.
Usenko et al. (2020) conducted an observational in Benign and malignant pathology of the pancreas and periampullary zone requiring pancreatoduodenectomy (n=60). Enhanced Recovery After Surgery (ERAS) program was evaluated on Feasibility of ERAS implementation and postoperative outcomes (length of stay, complications, mortality). Implementation of an Enhanced Recovery After Surgery (ERAS) program for pancreatoduodenectomy achieved high compliance rates, resulting in a mean hospital stay of 13.1 days, a 26.7% complication rate, and no postoperative mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: